Showing results (131-140 of 447) with videos related to
Sort By:
Pageof 45
Advances in Therapy|May 31, 2020
Treatment Sequencing in Patients with Anaplastic Lymphoma Kinase-Positive Non-Small Cell Lung Cancer in Japan: A Real-World Observational StudyYasushi Goto, Nobuyuki Yamamoto, Elizabeth T Masters, et al.Virchows Archiv : an International Journal of Pathology|October 28, 2022
Insulinoma-associated-1 (INSM1) expression in thymic squamous cell carcinomaJumpei Kashima, Taiki Hashimoto, Akihiko Yoshida, et al.Lung Cancer (Amsterdam, Netherlands)|June 8, 2020
Eltrombopag olamine for refractory immune-related thrombocytopenia induced by pembrolizumab in a non-small cell lung cancer patientMunehiro Ito, Shintaro Kanda, Tatsuya Yoshida, et al.Histopathology|July 30, 2025
Dynamic nature of hepatic differentiation in lung adenocarcinomaChihiro Takemura, Satsuki Kishikawa, Jumpei Kashima, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 22, 2021
An Alert to Possible False Positives With a Commercial Assay for MET Exon 14 SkippingTakashi Teishikata, Kouya Shiraishi, Yuki Shinno, et al.Thoracic Cancer|August 15, 2025
Effects of Sarcopenia on the Outcomes and Safety of Chemoradiotherapy Followed by Durvalumab for the Treatment of Patients With Locally Advanced Non-Small Cell Lung CancerKentaro Tamura, Hidehito Horinouchi, Mototaka Miyake, et al.Japanese Journal of Clinical Oncology|April 19, 2017
Efficacy and safety of osimertinib in a Japanese compassionate use programYutaka Fujiwara, Yasushi Goto, Shintaro Kanda, et al.Clinical Therapeutics|May 22, 2017
Systemic Treatment Patterns With Advanced or Recurrent Non-small Cell Lung Cancer in Japan: A Retrospective Hospital Administrative Database StudyFeng Wang, Sari Mishina, Shinji Takai, et al.Investigational New Drugs|May 4, 2011
Safety and pharmacokinetic study of nab-paclitaxel plus carboplatin in chemotherapy-naïve patients with advanced non-small cell lung cancerIsamu Okamoto, Nobuyuki Yamamoto, Kaoru Kubota, et al.Cancer Chemotherapy and Pharmacology|February 22, 2002
Enhanced antitumor activities of TZT-1027 against TNF-alpha or IL-6 secreting Lewis lung carcinoma in vivoTsugitaka Natsume, Yasuhiro Koh, Motohiro Kobayashi, et al.Pageof 45